ArticleAnnals of the rheumatic diseases2022

Correspondence to 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'.

Wenjie Zheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.